Nephrology

Anemia

Questions discussed in this category

What are the factors that you would consider for the use of ESA in patients with anemia of CKD with a history of stroke or TIA?

1 Answer available

Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?

1 Answer available

Papers discussed in this category

Am J Kidney Dis, 2019 Aug 05

The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach.

Circulation, 2011-12-20

What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013-01

Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.

American journal of nephrology, 2013

Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

Journal of the American Heart Association, 2021 Jun 26

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan.

Related Topics in Nephrology